SKYSTAR BIO-PHARMACEUTICAL CO Retained Earnings
SKYSTAR BIO-PHARMACEUTICAL CO had Retained Earnings of $63.69 million as of 2014-09-30, per its 10-Q filed 2014-11-14.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2014-11-14
- 2014-09-30: Retained Earnings (Accumulated Deficit) $63.69M.
- 2014-06-30: Retained Earnings (Accumulated Deficit) $58.78M.
- 2014-03-31: Retained Earnings (Accumulated Deficit) $55.97M.
- 2013-12-31: Retained Earnings (Accumulated Deficit) $54.99M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2014-09-30 | $63.69M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $58.78M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $55.97M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $54.99M 10-Q · filed 2014-11-14 |
| 2013-09-30 | $52.71M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $48.98M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $45.23M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $44.52M 10-K · filed 2014-03-31 |
| 2012-09-30 | $44.83M 10-Q · filed 2012-11-14 |
| 2012-06-30 | $42.10M 10-Q/A · filed 2012-09-13 |
| 2012-03-31 | $40.40M 10-Q · filed 2012-05-15 |
| 2011-12-31 | $38.49M 10-K · filed 2013-04-01 |
| 2011-09-30 | $36.01M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $28.29M 10-Q/A · filed 2011-09-21 |
| 2010-12-31 | $24.85M 10-K · filed 2012-03-30 |
| 2010-12-30 | $24.85M 10-Q · filed 2011-11-14 |